| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Atypical CML- the role of morphology and precision genomics
|
Lasho, Terra
|
|
|
33 |
2 |
p.
|
artikel
|
| 2 |
Autoimmune disease in CMML-the chicken or the egg?
|
Ambinder, Alexander J.
|
|
|
33 |
2 |
p.
|
artikel
|
| 3 |
Contemporary treatment approaches to CMML – Is allogeneic HCT the only cure?
|
Robin, Marie
|
|
|
33 |
2 |
p.
|
artikel
|
| 4 |
Editorial Board / Aims & Scope
|
|
|
|
33 |
2 |
p.
|
artikel
|
| 5 |
Establishing specific response criteria for MDS/MPN - Getting closer to reality?
|
Villaume, Matthew T.
|
|
|
33 |
2 |
p.
|
artikel
|
| 6 |
Incorporating flow cytometry and next-generation sequencing in the diagnosis of CMML. Are we ready for prime?
|
Solary, Eric
|
|
|
33 |
2 |
p.
|
artikel
|
| 7 |
Index
|
|
|
|
33 |
2 |
p.
|
artikel
|
| 8 |
Juvenile myelomonocytic leukemia – A bona fide RASopathy syndrome
|
Lasho, Terra
|
|
|
33 |
2 |
p.
|
artikel
|
| 9 |
MDS/MPN-RS-T justified inclusion as a unique disease entity?
|
Montalban-Bravo, Guillermo
|
|
|
33 |
2 |
p.
|
artikel
|
| 10 |
Moving towards a uniform risk stratification system in CMML - How far are we?
|
Chan, Onyee
|
|
|
33 |
2 |
p.
|
artikel
|
| 11 |
Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?
|
Sangiorgio, V.F.I.
|
|
|
33 |
2 |
p.
|
artikel
|
| 12 |
Myelodysplastic/myeloproliferative neoplasms – Justified inclusion as unique biological entities
|
Patnaik, Mrinal M.
|
|
|
33 |
2 |
p.
|
artikel
|
| 13 |
Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a “catch-all” term?
|
Shallis, Rory M.
|
|
|
33 |
2 |
p.
|
artikel
|
| 14 |
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes – Advances in treatment
|
McCullough, Kristen B.
|
|
|
33 |
2 |
p.
|
artikel
|
| 15 |
Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management
|
Valent, Peter
|
|
|
33 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving